project id: TCGA-SKCM; case submitter id: TCGA-EB-A5UM; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.17; rna integrity number: 7.5; age at index: 48; days to birth: -17867; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1964; age at diagnosis: 17867; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 779.0; icd 10 code: C44.5; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin of trunk; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 92; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-EB-A5UM-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 40.0; percent stromal cells: 0.0; percent tumor cells: 60.0; percent tumor nuclei: 75.0;